Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1990 2
1991 3
1992 4
1993 4
1994 11
1995 1
1996 6
1997 9
1998 13
1999 13
2000 11
2001 13
2002 8
2003 13
2004 10
2005 8
2006 13
2007 11
2008 19
2009 8
2010 12
2011 17
2012 11
2013 14
2014 10
2015 11
2016 17
2017 13
2018 8
2019 11
2020 7
2021 13
2022 15
2023 8
2024 11
2025 13
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean dtasken k (784,075 results)?
Cyclic nucleotide phosphodiesterases as drug targets.
Kelly MP, Nikolaev VO, Gobejishvili L, Lugnier C, Hesslinger C, Nickolaus P, Kass DA, Pereira de Vasconcelos W, Fischmeister R, Brocke S, Epstein PM, Piazza GA, Keeton AB, Zhou G, Abdel-Halim M, Abadi AH, Baillie GS, Giembycz MA, Bolger G, Snyder G, Tasken K, Saidu NEB, Schmidt M, Zaccolo M, Schermuly RT, Ke H, Cote RH, Mohammadi Jouabadi S, Roks AJM. Kelly MP, et al. Among authors: tasken k. Pharmacol Rev. 2025 May;77(3):100042. doi: 10.1016/j.pharmr.2025.100042. Epub 2025 Jan 22. Pharmacol Rev. 2025. PMID: 40081105 Free article. Review.
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Sumnik Z, Sediva A, Slatter M, Arkwright PD, Cant A, Lorenz HM, Giese T, Lougaris V, Plebani A, Price C, Sullivan KE, Moutschen M, Litzman J, Freiberger T, van de Veerdonk FL, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Speckmann C, Ehl S, Leichtner A, Blumberg R, Franke A, Snapper S, Zeissig S, Cunningham-Rundles C, Giulino-Roth L, Elemento O, Dückers G, Niehues T, Fronkova E, Kanderová V, Platt CD, Chou J, Chatila TA, Geha R, McDermott E, Bunn S, Kurzai M, Schulz A, Alsina L, Casals F, Deyà-Martinez A, Hambleton S, Kanegane H, Taskén K, Neth O, Grimbacher B. Schwab C, et al. Among authors: tasken k. J Allergy Clin Immunol. 2018 Dec;142(6):1932-1946. doi: 10.1016/j.jaci.2018.02.055. Epub 2018 May 4. J Allergy Clin Immunol. 2018. PMID: 29729943 Free PMC article.
FOXK1 and FOXK2 regulate aerobic glycolysis.
Sukonina V, Ma H, Zhang W, Bartesaghi S, Subhash S, Heglind M, Foyn H, Betz MJ, Nilsson D, Lidell ME, Naumann J, Haufs-Brusberg S, Palmgren H, Mondal T, Beg M, Jedrychowski MP, Taskén K, Pfeifer A, Peng XR, Kanduri C, Enerbäck S. Sukonina V, et al. Among authors: tasken k. Nature. 2019 Feb;566(7743):279-283. doi: 10.1038/s41586-019-0900-5. Epub 2019 Jan 30. Nature. 2019. PMID: 30700909
Nobelpris for regulatoriske T-celler og immuntoleranse.
Myklebust J, Taskén K. Myklebust J, et al. Among authors: tasken k. Tidsskr Nor Laegeforen. 2025 Nov 24;145(15). doi: 10.4045/tidsskr.25.0649. Print 2025 Dec 16. Tidsskr Nor Laegeforen. 2025. PMID: 41410971 Free article. Norwegian. No abstract available.
Cancer treatment paradigms in the precision medicine era.
Subbiah V, Curigliano G, Sicklick JK, Kato S, Tasken K, Medford A, Rieke DT, Chen HZ, Wahida A, Buschhorn L, Horgan D, Kurzrock R. Subbiah V, et al. Among authors: tasken k. Nat Med. 2025 Nov;31(11):3609-3611. doi: 10.1038/s41591-025-03711-w. Nat Med. 2025. PMID: 40394190 No abstract available.
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Taskén K, Haj Mohammad SF, Fagereng GL, Sørum Falk R, Helland Å, Barjesteh van Waalwijk van Doorn-Khosrovani S, Steen Carlsson K, Ryll B, Jalkanen K, Edsjö A, Russnes HG, Lassen U, Hallersjö Hult E, Lugowska I, Blay JY, Verlingue L, Abel E, Lowery MA, Krebs MG, Staal Rohrberg K, Ojamaa K, Oliveira J, Verheul HMW, Voest EE, Gelderblom H; PRIME-ROSE Consortium and the PCM4EU Consortium. Taskén K, et al. Acta Oncol. 2024 May 23;63:385-391. doi: 10.2340/1651-226X.2024.34791. Acta Oncol. 2024. PMID: 38779910 Free PMC article.
β-Adrenergic Receptor Signaling in Prostate Cancer.
Braadland PR, Ramberg H, Grytli HH, Taskén KA. Braadland PR, et al. Among authors: tasken ka. Front Oncol. 2015 Jan 12;4:375. doi: 10.3389/fonc.2014.00375. eCollection 2014. Front Oncol. 2015. PMID: 25629002 Free PMC article. Review.
[Raising the quality of cancer treatment].
Helland Å, Steinskog ESS, Blix ES, Flobak Å, Brabrand S, Puco K, Niehusmann P, Meltzer S, Oppedal IA, Haug Å, Torkildsen CF, Randen U, Gilje B, Lønning PE, Gjertsen BT, Hovland R, Russnes HG, Fagereng GL, Smeland S, Tasken K. Helland Å, et al. Among authors: tasken k. Tidsskr Nor Laegeforen. 2024 Jan 18;144(1). doi: 10.4045/tidsskr.23.0740. Print 2024 Jan 23. Tidsskr Nor Laegeforen. 2024. PMID: 38258713 Free article. Norwegian. No abstract available.
CD147 in regulatory T cells.
Landskron J, Taskén K. Landskron J, et al. Among authors: tasken k. Cell Immunol. 2013 Mar;282(1):17-20. doi: 10.1016/j.cellimm.2013.04.008. Epub 2013 Apr 26. Cell Immunol. 2013. PMID: 23665204 Review.
343 results